Skip to main content

Advertisement

SpringerLink
Log in

SPAG9 is overexpressed in human prostate cancer and promotes cancer cell proliferation

  • Research Article
  • Published:
Tumor Biology

Abstract

Sperm-associated antigen 9 (SPAG9) was recently reported to be overexpressed in several cancers and associated with the malignant behavior of cancer cells. However, the expression pattern of SPAG9 and its clinical significance in human prostate cancer have not been reported. In the present study, we analyzed SPAG9 expression in human prostate cancer tissues by immunohistochemistry and found that SPAG9 was overexpressed in 36.5 % of prostate cancer specimens. There was a significant association between SPAG9 overexpression and tumor stage (p = 0.0020) and Gleason score (p = 0.0377). Transfection of SPAG9 plasmid was performed in PC-3 cell line and siRNA knockdown was carried out in DU145 cells. Colony formation and MTT showed that SPAG9 overexpression promoted while siRNA knockdown inhibited prostate cancer cell proliferation. In addition, we found that SPAG9 could regulate cyclin D1 and cyclin E protein expression. In conclusion, SPAG9 is overexpressed in human prostate cancers and contributes to prostate cancer cell growth, possibly through cyclin protein regulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62(1):10–29.

    Article  PubMed  Google Scholar 

  2. Yaqinuddin A, Qureshi SA, Pervez S, Bashir MU, Nazir R, Abbas F. Frequent DNA hypermethylation at the RASSF1A and APC gene loci in prostate cancer patients of Pakistani Origin. ISRN Urol. 2013;2013:627249.

    PubMed Central  PubMed  Google Scholar 

  3. Amin KS, Banerjee PP. The cellular functions of RASSF1A and its inactivation in prostate cancer. J Carcinog. 2012;11:3.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Syeed N, Syed Sameer A, Hamid A, Shah ZA, Afroze D, Rasool R, et al. Promoter methylation profile of GSTP1 and RASSF1A in benign hyperplasia and metastatic prostate cancer patients in a Kashmiri population. Mol Med Rep. 2010;3(5):883–7.

    CAS  PubMed  Google Scholar 

  5. Ando K, Uemura K, Kuzuya A, Maesako M, Asada-Utsugi M, Kubota M, et al. N-cadherin regulates p38 MAPK signaling via association with JNK-associated leucine zipper protein: implications for neurodegeneration in Alzheimer disease. J Biol Chem. 2013;286(9):7619–28.

    Article  Google Scholar 

  6. Kashef K, Lee CM, Ha JH, Reddy EP, Dhanasekaran DN. JNK-interacting leucine zipper protein is a novel scaffolding protein in the Galpha13 signaling pathway. Biochemistry. 2005;44(43):14090–6.

    Article  CAS  PubMed  Google Scholar 

  7. Lee CM, Onesime D, Reddy CD, Dhanasekaran N, Reddy EP. JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors. Proc Natl Acad Sci U S A. 2002;99(22):14189–94.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Nguyen Q, Lee CM, Le A, Reddy EP. JLP associates with kinesin light chain 1 through a novel leucine zipper-like domain. J Biol Chem. 2005;280(34):30185–91.

    Article  CAS  PubMed  Google Scholar 

  9. Takaesu G, Kang JS, Bae GU, Yi MJ, Lee CM, Reddy EP, et al. Activation of p38alpha/beta MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein Cdo. J Cell Biol. 2006;175(3):383–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Kanojia D, Garg M, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(2):630–9.

    Article  CAS  PubMed  Google Scholar 

  11. Garg M, Kanojia D, Suri S, Suri A. Small interfering RNA-mediated down-regulation of SPAG9 inhibits cervical tumor growth. Cancer. 2009;115(24):5688–99.

    Article  CAS  PubMed  Google Scholar 

  12. Garg M, Kanojia D, Salhan S, Suri S, Gupta A, Lohiya NK, et al. Sperm-associated antigen 9 is a biomarker for early cervical carcinoma. Cancer. 2009;115(12):2671–83.

    Article  CAS  PubMed  Google Scholar 

  13. Garg M, Kanojia D, Suri S, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9: a novel diagnostic marker for thyroid cancer. J Clin Endocrinol Metab. 2009;94(11):4613–8.

    Article  CAS  PubMed  Google Scholar 

  14. Kanojia D, Garg M, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity. Am J Pathol. 2011;178(3):1009–20.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Yi F, Ni W, Liu W, Pan X, Han X, Yang L, et al. SPAG9 is overexpressed in human astrocytoma and promotes cell proliferation and invasion. Tumour Biol. 2013;34(5):2849–55.

    Article  CAS  PubMed  Google Scholar 

  16. Wang Y, Dong Q, Miao Y, Fu L, Lin X, Wang E. Clinical significance and biological roles of SPAG9 overexpression in non-small cell lung cancer. Lung Cancer. 2013;81(2):266–72.

    Article  PubMed  Google Scholar 

  17. Garg M, Kanojia D, Khosla A, Dudha N, Sati S, Chaurasiya D, et al. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma. Cancer Res. 2008;68(20):8240–8.

    Article  CAS  PubMed  Google Scholar 

  18. Jagadish N, Rana R, Selvi R, Mishra D, Garg M, Yadav S, et al. Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal kinase-interacting protein. Biochem J. 2005;389(Pt 1):73–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Gantulga D, Tuvshintugs B, Endo Y, Takino T, Sato H, Murakami S, et al. The scaffold protein c-Jun NH2-terminal kinase-associated leucine zipper protein regulates cell migration through interaction with the G protein G(alpha 13). J Biochem. 2008;144(6):693–700.

    Article  CAS  PubMed  Google Scholar 

  20. Kashef K, Radhakrishnan R, Lee CM, Reddy EP, Dhanasekaran DN. Neoplastic transformation induced by the gep oncogenes involves the scaffold protein JNK-interacting leucine zipper protein. Neoplasia. 2011;13(4):358–64.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem. 2003;253(1–2):269–85.

    Article  CAS  PubMed  Google Scholar 

  22. Kanojia D, Garg M, Saini S, Agarwal S, Parashar D, Jagadish N, et al. Sperm-associated antigen 9 plays an important role in bladder transitional cell carcinoma. PLoS One. 2013;8(12):e81348.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 1994;79(4):573–82.

    Article  CAS  PubMed  Google Scholar 

  24. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer. 2011;11(8):558–72.

    Article  CAS  PubMed  Google Scholar 

  25. Liu Y, Wang L, Lin XY, Wang J, Yu JH, Miao Y, et al. The transcription factor DEC1 (BHLHE40/STRA13/SHARP-2) is negatively associated with TNM stage in non-small-cell lung cancer and inhibits the proliferation through cyclin D1 in A549 and BE1 cells. Tumour Biol. 2013;34(3):1641–50.

    Article  CAS  PubMed  Google Scholar 

  26. Liu J, Liao Q, Zhang Y, Sun S, Zhong C, Liu X. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis. Tumour Biol. 2012;33(5):1467–76.

    Article  CAS  PubMed  Google Scholar 

  27. Vizkeleti L, Ecsedi S, Rakosy Z, Orosz A, Lazar V, Emri G, et al. The role of CCND1 alterations during the progression of cutaneous malignant melanoma. Tumour Biol. 2012;33(6):2189–99.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

The study was supported by the Outstanding Scientific Fund of Shengjing Hospital (no. 201205).

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Geriatrics, Shengjing Hospital of China Medical University, 36 Sanhao Road, Shenyang, 110004, China

    Hui Li, Yang Peng, Huiyan Niu, Baogang Wu, Yi Zhang, Yue Zhang, Xue Bai & Ping He

Authors
  1. Hui Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yang Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huiyan Niu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Baogang Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yue Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xue Bai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ping He
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ping He.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, H., Peng, Y., Niu, H. et al. SPAG9 is overexpressed in human prostate cancer and promotes cancer cell proliferation. Tumor Biol. 35, 6949–6954 (2014). https://doi.org/10.1007/s13277-014-1947-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-1947-4

Keywords

Search

Navigation